MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer — Papers | ScholarIQ

Scholar IQ

Help

Try ScholarIQ free

Upload Records Snowball Search Search OpenAlex

About the database

ScholarIQanswers from OpenAlex

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

PaperCitations, authors & open-access status

2,426

Citations

2,014

Year

closed

OA Status

IDs:DOI PMID OpenAlex

Related on ScholarIQ

Cancer Immunotherapy and Biomarkers

Bladder and Urothelial Cancer Treatments

Cancer Immunotherapy and Biomarkers